KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Payables (2016 - 2026)

Fulgent Genetics' Payables history spans 12 years, with the latest figure at $21.6 million for Q1 2026.

  • On a quarterly basis, Payables rose 15.46% to $21.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $21.6 million, a 15.46% increase, with the full-year FY2025 number at $19.1 million, up 1.89% from a year prior.
  • Payables hit $21.6 million in Q1 2026 for Fulgent Genetics, up from $19.1 million in the prior quarter.
  • Over the last five years, Payables for FLGT hit a ceiling of $42.9 million in Q2 2022 and a floor of $16.5 million in Q4 2023.
  • Historically, Payables has averaged $22.7 million across 5 years, with a median of $20.0 million in 2024.
  • Biggest five-year swings in Payables: soared 191.0% in 2022 and later tumbled 42.42% in 2023.
  • Tracing FLGT's Payables over 5 years: stood at $28.7 million in 2022, then tumbled by 42.42% to $16.5 million in 2023, then grew by 13.5% to $18.8 million in 2024, then grew by 1.89% to $19.1 million in 2025, then rose by 12.95% to $21.6 million in 2026.
  • Business Quant data shows Payables for FLGT at $21.6 million in Q1 2026, $19.1 million in Q4 2025, and $18.6 million in Q3 2025.